Underutilisation of breast cancer prevention medication in Australia.
Breast
; 60: 35-37, 2021 Dec.
Article
em En
| MEDLINE
| ID: mdl-34455228
ABSTRACT
Increased implementation of proven prevention strategies is required to combat rising breast cancer incidence. We assessed use of risk reducing medication (RRMed) by Australian women at elevated breast cancer risk. Only 2.4% had ever used RRMed. Higher breast cancer risk was statistically significantly associated with use of RRMed (OR 1.82, 95%CI 1.08-3.07, p = 0.02 for ≥30% lifetime risk compared with 16%-29% lifetime risk), but parity, education level and family history of breast cancer were not. Breast cancer prevention medications are underutilised. Efforts are needed to incorporate breast cancer risk assessment and risk management discussions into routine health assessments for women.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Tamoxifeno
/
Neoplasias da Mama
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article